Concepedia

Iris Gehrke

IG

Statistics

Publications

13

Citations

828

H-Index

12

Active since

2008

Affiliations

University of Cologne(Current)

University Hospital Cologne

Novartis (Germany)

University of Manitoba

Novartis (Switzerland)

Iris Gehrke is an author at University of Cologne specializing in oncology, molecular oncology, and pharmacology.

Publications per year

2008–2020

13

Publications

13

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation

F. La Rosée, Hinrich Bremer, Iris Gehrke et al. · Leukemia · 2020 · 243 citations · Full text

, , +17

Small Molecule Inhibitors of Wnt/β-Catenin/Lef-1 Signaling Induces Apoptosis in Chronic Lymphocytic Leukemia Cells In Vitro and In Vivo

Rajesh Kumar Gandhirajan, Peter Staib, Katharina Minke et al. · Neoplasia · 2010 · 117 citations · Full text

, , +16

Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells

Katharina Minke, Peter Staib, Adriane Puetter et al. · European Journal Of Haematology · 2008 · 82 citations

, , +14

On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells

Iris Gehrke, Eric D.J. Bouchard, Sara Beiggi et al. · Clinical Cancer Research · 2014 · 80 citations

, , +17

Targeting the WNT/β-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options

Iris Gehrke, Rajesh Kumar Gandhirajan, Karl‐Anton Kreuzer · European Journal of Cancer · 2009 · 73 citations

, , +16

1–5 of 13